La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
4013 Panoramica delle azioni
L'azienda Dr. Sulaiman Al Habib Medical Services Group fonda, gestisce e opera ospedali, complessi medici generali e specializzati, centri di day surgery e strutture farmaceutiche in Arabia Saudita e a livello internazionale.
Punteggio fiocco di neve | |
---|---|
Valutazione | 2/6 |
Crescita futura | 4/6 |
Prestazioni passate | 3/6 |
Salute finanziaria | 3/6 |
Dividendi | 1/6 |
Dr. Sulaiman Al Habib Medical Services Group Company Concorrenti
Storia dei prezzi e prestazioni
Prezzi storici delle azioni | |
---|---|
Prezzo attuale dell'azione | ر.س300.20 |
Massimo di 52 settimane | ر.س346.80 |
Minimo di 52 settimane | ر.س223.20 |
Beta | 0.69 |
1Variazione di 1 mese | -1.12% |
Variazione a 3 mesi | 4.02% |
Variazione di 1 anno | 27.42% |
3Variazione a 3 anni | 72.53% |
Variazione a 5 anni | n/a |
Variazione dall'IPO | 460.07% |
Notizie e aggiornamenti recenti
Investors Will Want Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Growth In ROCE To Persist
Jul 04Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
May 23Recent updates
Investors Will Want Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Growth In ROCE To Persist
Jul 04Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
May 23Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
May 08Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
May 03Subdued Growth No Barrier To Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Price
Apr 29There's Been No Shortage Of Growth Recently For Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital
Mar 15Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Dividend Will Be SAR1.15
Feb 22With EPS Growth And More, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Makes An Interesting Case
Feb 20Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Price Is Out Of Tune With Earnings
Jan 09We Like These Underlying Return On Capital Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013)
Nov 28We Think That There Are Issues Underlying Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Earnings
Nov 07Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 02Here's Why Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Has Caught The Eye Of Investors
Sep 21Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Doing The Right Things To Multiply Its Share Price
Aug 10Here's Why We Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Well Worth Watching
Jun 17Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
May 12Returns At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Are On The Way Up
May 06Here's Why We Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Mar 13Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital Are Heading Higher
Jan 30With EPS Growth And More, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Makes An Interesting Case
Dec 07Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Doing The Right Things To Multiply Its Share Price
Oct 23If EPS Growth Is Important To You, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Presents An Opportunity
Sep 08Estimating The Intrinsic Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Aug 24Why Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Could Be Worth Watching
Aug 08Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Has More To Do To Multiply In Value Going Forward
Jul 12Does Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Deserve A Spot On Your Watchlist?
May 31A Look At The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
May 17Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Will Pay A Larger Dividend Than Last Year At ر.س0.83
Apr 28Should You Think About Buying Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Now?
Apr 09Return Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Aren't Appealing
Mar 06Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is An Interesting Stock
Feb 16Returns On Capital At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Have Stalled
Dec 05Do Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Earnings Warrant Your Attention?
Nov 17Investors Could Be Concerned With Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital
Aug 30Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Aug 01Estimating The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Jun 11Capital Allocation Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Aren't Ideal
May 27Earnings Beat: Dr. Sulaiman Al Habib Medical Services Group Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 27Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Apr 06A Look At The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Feb 04Is Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Shareholder Ownership Skewed Towards Insiders?
Jan 14Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Is Yielding 1.5% - But Is It A Buy?
Dec 23Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Nov 27Rendimenti per gli azionisti
4013 | SA Healthcare | SA Mercato | |
---|---|---|---|
7D | 0.3% | 1.2% | 1.7% |
1Y | 27.4% | 21.6% | -11.3% |
Ritorno vs Industria: 4013 ha superato il SA Healthcare che ha restituito 16.9 % nell'ultimo anno.
Rendimento vs Mercato: 4013 ha superato il mercato SA che ha restituito -11.7 % nell'ultimo anno.
Volatilità dei prezzi
4013 volatility | |
---|---|
4013 Average Weekly Movement | 2.9% |
Healthcare Industry Average Movement | 4.9% |
Market Average Movement | 4.5% |
10% most volatile stocks in SA Market | 7.8% |
10% least volatile stocks in SA Market | 2.6% |
Prezzo delle azioni stabile: 4013 non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.
Volatilità nel tempo: La volatilità settimanale ( 4% ) di 4013 è rimasta stabile nell'ultimo anno.
Informazioni sull'azienda
Fondato | I dipendenti | AMMINISTRATORE DELEGATO | Sito web |
---|---|---|---|
1993 | n/a | Faisal Abdullah Al Nassar | www.hmg.com |
La Dr. Sulaiman Al Habib Medical Services Group Company fonda, gestisce e opera ospedali, complessi medici generali e specializzati, centri di day surgery e strutture farmaceutiche in Arabia Saudita e a livello internazionale. Gestisce ospedali per la maternità, l'ortopedia e la chirurgia spinale. L'azienda gestisce anche centri di dermatologia, chirurgia plastica, oftalmologia, trattamento dell'obesità e della fertilità, nonché farmacie.
Dr. Sulaiman Al Habib Medical Services Group Company Riepilogo dei fondamenti
4013 statistiche fondamentali | |
---|---|
Capitalizzazione di mercato | ر.س105.07b |
Guadagni(TTM) | ر.س2.18b |
Ricavi(TTM) | ر.س10.02b |
48.3x
Rapporto P/E10.5x
Rapporto P/S4013 è sopravvalutato?
Vedi Fair Value e analisi di valutazioneGuadagni e ricavi
4013 Conto economico (TTM) | |
---|---|
Ricavi | ر.س10.02b |
Costo del fatturato | ر.س6.57b |
Profitto lordo | ر.س3.45b |
Altre spese | ر.س1.27b |
Guadagni | ر.س2.18b |
Ultimi guadagni dichiarati
Jun 30, 2024
Prossima data di guadagno
n/a
Utile per azione (EPS) | 6.22 |
Margine lordo | 34.42% |
Margine di profitto netto | 21.70% |
Rapporto debito/patrimonio netto | 78.6% |
Come si è comportato 4013 nel lungo periodo?
Vedi performance storica e confronto